Format

Send to

Choose Destination
Cell Cycle. 2014;13(24):3921-6. doi: 10.4161/15384101.2014.973324.

USP7 controls Chk1 protein stability by direct deubiquitination.

Author information

1
a Unidad de Investigación ; Hospital Universitario de Canarias ; Instituto de Tecnologías Biomédicas ; Tenerife , Spain.

Abstract

Chk1, an essential checkpoint kinase in the DNA damage response pathway (DDR), is tightly regulated by both ATR-dependent phosphorylation and proteasome-mediated degradation. Here we identify ubiquitin hydrolase USP7 as a novel regulator of Chk1 protein stability. USP7 was shown before to regulate other DDR proteins such as p53, Hdm2 and Claspin, an adaptor protein in the ATR-Chk1 pathway required for Chk1 activation. Depletion or inhibition of USP7 leads to lower Chk1 levels. The decreased Chk1 protein after USP7 knock down cannot be rescued by simultaneously elevating Claspin levels, demonstrating that the effect of USP7 on Chk1 is independent of its known effect on Claspin. Conversely, overexpression of USP7 wild type, but not a catalytic mutant version, elevates Chk1 levels and increases the half-life of Chk1 protein. Importantly, wild type, but not catalytic mutant USP7 can deubiquitinate Chk1 in vivo and in vitro, confirming that USP7 directly regulates Chk1 protein levels. Finally we show that USP7 catalytic mutant is (mono-)ubiquitinated, which suggests auto-deubiquitination by this ubiquitin hydrolase, possibly important for its regulation.

KEYWORDS:

CI, catalytic inactive; Chk1; DDR, DNA damage response; DUB, deubiquitylating enzyme; USP, ubiquitin specific peptidase; USP7; WT, wild type; claspin; ubiquitin hydrolase

PMID:
25483066
PMCID:
PMC4614819
DOI:
10.4161/15384101.2014.973324
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center